← Back to headlines
United Therapeutics Stock Surges on Positive Tyvaso Trial Results
United Therapeutics shares have surged following positive results from trials of its drug Tyvaso, which is being developed for the treatment of idiopathic pulmonary fibrosis.
30 Mar, 15:41 — 30 Mar, 15:41
Sources
Showing 1 of 1 sources
